PT - JOURNAL ARTICLE AU - Lara Tang AU - Tess Levy AU - Sylvia Guillory AU - Danielle Halpern AU - Jessica Zweifach AU - Ivy Giserman Kiss AU - Jennifer H Foss-Feig AU - Yitzchak Frank AU - Reymundo Lozano AU - Puneet Belani AU - Christina Layton AU - Emanuel Frowner AU - Michael S. Breen AU - Silvia De Rubeis AU - Ana Kostic AU - Alexander Kolevzon AU - Joseph D Buxbaum AU - Paige M Siper AU - Dorothy E Grice TI - Prospective and detailed behavioral phenotyping in DDX3X syndrome AID - 10.1101/2021.01.26.21250125 DP - 2021 Jan 01 TA - medRxiv PG - 2021.01.26.21250125 4099 - http://medrxiv.org/content/early/2021/01/29/2021.01.26.21250125.short 4100 - http://medrxiv.org/content/early/2021/01/29/2021.01.26.21250125.full AB - Background DDX3X syndrome is a recently identified genetic disorder that accounts for 1-3% of cases of unexplained developmental delay (DD) and/or intellectual disability (ID) in females and is associated with motor and language delays, and autism spectrum disorder (ASD). To date, the published phenotypic characterization of this syndrome has primarily relied on medical record review; in addition, the behavioral dimensions of the syndrome have not been fully explored.Methods We carried out multi-day, prospective, detailed phenotyping of DDX3X syndrome in 14 females and 1 male, focusing on behavioral, psychological, and neurological measures; three participants in this cohort have been previously reported. We compared results against population norms and contrasted phenotypes between individuals harboring either (i) protein-truncating variants or (ii) missense variants and in-frame deletions.Results Eighty percent of individuals met criteria for ID, 60% for ASD and 53% for attention-deficit/hyperactivity disorder (ADHD). Motor and language delays were common as were sensory processing abnormalities. The cohort included 5 missense, 3 intronic/splice-site, 2 nonsense, 2 frameshift, 2 in-frame deletions, and one initiation codon variant. Genotype-phenotype correlations indicated that missense variants/in-frame deletions were associated with more severe language, motor, and adaptive deficits in comparison to protein-truncating variants.Limitations Sample size is modest, however, DDX3X is a rare and underdiagnosed disorder.Conclusion This study, representing a first, prospective, detailed characterization of DDX3X syndrome, extends our understanding of the neurobehavioral phenotype. Gold-standard diagnostic approaches demonstrated high rates of ID, ASD, and ADHD. In addition, sensory deficits were observed to be a key part of the syndrome. Even with a modest sample, we observe evidence for genotype-phenotype correlations with missense variants/in-frame deletions yielding a more severe phenotype.Competing Interest StatementA. Kolevzon receives research support from AMO Pharma and consults to Ovid Therapeutics, Acadia, and Sema4. PMS and Mount Sinai licensed the Sensory Assessment for Neurodevelopmental Disorders (SAND) licensed by PMS to Stoelting, Co. No other competing interests to declare. Funding StatementFunding was provided by the Beatrice and Samuel A. Seaver Foundation. The study sponsors had no role in the study design; in the collection, analysis and interpretation of the data; in the writing of the report; and in the decision to submit the paper for publication. SDR is a Fascitelli Research Scholar. MSB is a Seaver Faculty Scholar.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Parents or legal guardians of all participants in this study provided informed consent prior to study participation. This study was approved by the Mouth Sinai Institutional Review Board, Program for the Protection of Human Subjects (Study ID: 98- 436).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe majority of the dataset used during the current study is included in this published article and Supplementary File. The remainder of the dataset is available from the corresponding author on reasonable request and may require ethics review.ADHDAttention Deficit/Hyperactivity DisorderADIAutism Diagnostic InterviewADI-RAutism Diagnostic Interview-RevisedADOS-2Autism Diagnostic Observation Schedule, Second EditionASDAutism Spectrum DisorderBMIBody Mass IndexCBCLAchenbach Child Behavior ChecklistDAS-IIDifferential Ability Scales-Second EditionDCDQDevelopmental Coordination Disorder QuestionnaireDDDevelopmental DelayDQDevelopmental QuotientDSM-5Diagnostic and Statistical Manual, Fifth Edition ID Intellectual DisabilityIQIntellectual QuotientMCDIMacArthur-Bates Communicative Development InventoryMRIMagnetic Resonance ImagingMullenScales Mullen Scales of Early LearningNICUNeonatal Intensive Care UnitNDDsNeurodevelopmental DisordersPDDBIPervasive Developmental Disorder Behavior InventoryPMGPolymicrogyriaPTVProtein Truncating VariantRBS-RRepetitive Behavior Scale-RevisedSANDSensory Assessment for Neurodevelopmental DisordersSB-5Stanford-Binet Intelligence Scales, Fifth EditionSRS-2Social Responsiveness Scale, Second EditionSSPShort Sensory ProfileTDTypically DevelopingVineland-3Vineland Adaptive Behavior Scales, Third EditionVMI-6Beery-Buktenica Developmental Test of Visual-Motor Integration, Sixth Edition